Jones Financial Companies’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.3M Buy
619,316
+113,736
+22% +$8.88M 0.02% 372
2025
Q4
$37.9M Buy
505,580
+148,904
+42% +$11.1M 0.02% 220
2025
Q3
$26M Buy
356,676
+77,808
+28% +$5.58M 0.02% 248
2025
Q2
$19.7M Buy
278,868
+91,231
+49% +$6.08M 0.02% 260
2025
Q1
$12.1M Buy
187,637
+46,602
+33% +$2.92M 0.01% 290
2024
Q4
$8.25M Buy
141,035
+58,677
+71% +$3.66M 0.01% 290
2024
Q3
$5.46M Buy
82,358
+57,150
+227% +$3.66M 0.01% 282
2024
Q2
$1.58M Buy
25,208
+21,741
+627% +$1.36M ﹤0.01% 355
2024
Q1
$217K Buy
3,467
+3,045
+722% +$182K ﹤0.01% 451
2023
Q4
$24.7K Buy
+422
New +$23.5K ﹤0.01% 561

Other funds holding JIRE

Jones Financial Companies's JIRE Position: Q1 2026 in Review

Jones Financial Companies increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 22% in Q1 2026, buying an estimated $8.88M and bringing the position to 619,316 shares worth $45.3M. The position accounts for 0.02% of the portfolio, ranked #372.

Jones Financial Companies first reported a position in JIRE in Q4 2023 and has held it in 10 quarters since. 339 funds tracked by Wall St. Rank hold JIRE as of Q1 2026.

  • Jones Financial Companies held 619,316 shares of JPMorgan International Research Enhanced Equity ETF worth $45.3M as of Q1 2026.
  • Jones Financial Companies bought 113,736 JPMorgan International Research Enhanced Equity ETF shares in Q1 2026, an estimated $8.88M.
  • JPMorgan International Research Enhanced Equity ETF made up 0.02% of Jones Financial Companies's portfolio in Q1 2026, its #372 holding.
  • Jones Financial Companies first reported a position in JPMorgan International Research Enhanced Equity ETF in Q4 2023 and has held it in 10 quarters since.
  • 339 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.